Pruritis News and Research

RSS
Novel treatment for polycythemia vera shows promise in clinical trial

Novel treatment for polycythemia vera shows promise in clinical trial

Study finds gut health key to combating skin diseases, eyes probiotics as potential treatment

Study finds gut health key to combating skin diseases, eyes probiotics as potential treatment

CDC report highlights urgent need for guideline adherence in prescribing antifungal medications

CDC report highlights urgent need for guideline adherence in prescribing antifungal medications

Study suggests a single dose of JYNNEOS vaccine may lessen the severity of mpox illness

Study suggests a single dose of JYNNEOS vaccine may lessen the severity of mpox illness

FLASH radiotherapy may hold promise as a potential treatment for tough-to-kill tumors

FLASH radiotherapy may hold promise as a potential treatment for tough-to-kill tumors

Could COVID-19 infections trigger a relapse of mycosis fungoides or other cutaneous T-cell lymphomas?

Could COVID-19 infections trigger a relapse of mycosis fungoides or other cutaneous T-cell lymphomas?

Study develops single-use microneedle patch tattoos with wide-ranging application potential

Study develops single-use microneedle patch tattoos with wide-ranging application potential

CDC report shows people with monkeypox have higher than expected rates of HIV and STIs

CDC report shows people with monkeypox have higher than expected rates of HIV and STIs

Clinical presentation of monkeypox infection in two Israeli males

Clinical presentation of monkeypox infection in two Israeli males

Study investigates if COVID-19 restrictions were associated with differences in health and lifestyle of Labradors

Study investigates if COVID-19 restrictions were associated with differences in health and lifestyle of Labradors

Influenza and COVID vaccines can be co-administered in older adults without causing severe side effects

Influenza and COVID vaccines can be co-administered in older adults without causing severe side effects

Symptom under-recognition may be common in breast cancer patients treated with radiotherapy

Symptom under-recognition may be common in breast cancer patients treated with radiotherapy

Phase 2 IMAGO trial of SHP625 fails to meet primary endpoints in pediatric patients with ALGS

Phase 2 IMAGO trial of SHP625 fails to meet primary endpoints in pediatric patients with ALGS

Cipher acquires worldwide rights to three products from Astion

Cipher acquires worldwide rights to three products from Astion

Gilead reports topline results from sofosbuvir Phase 3 trial in Japan for treatment of HCV infection

Gilead reports topline results from sofosbuvir Phase 3 trial in Japan for treatment of HCV infection

Gilead Sciences gets marketing authorization from European Commission for Sovaldi 400 mg tablets

Gilead Sciences gets marketing authorization from European Commission for Sovaldi 400 mg tablets

Immunologic checkpoint inhibitor shows promise in malignant mesothelioma

Immunologic checkpoint inhibitor shows promise in malignant mesothelioma

Peripheral neuropathic pain patch treatments: an interview with Anne Hodgkins, Astellas Pharma

Peripheral neuropathic pain patch treatments: an interview with Anne Hodgkins, Astellas Pharma

Gilead Sciences to present results from four Phase 3 clinical trials at International Liver Congress 2013

Gilead Sciences to present results from four Phase 3 clinical trials at International Liver Congress 2013

Study supports sphincter-saving surgery

Study supports sphincter-saving surgery

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.